The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 7
- 0 vs. Q2 2022
- Portfolio value
- $451.8M
- −$18.0M (−3.8%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,309,329 | $2.46M | 0.5% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,568,181 | $11.4M | 2.5% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 9,248,129 | $18.7M | 4.1% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $27.3M | 6.0% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,680,458 | $64.5M | 14.3% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 4,577,840 | $90.3M | 20.0% | +182,790+4.2% | Added | History |
| NGMNGM Biopharmaceuticals Inc | COM | 18,136,735 | $237.2M | 52.5% | 00.0% | Unchanged | History |